Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Müller

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
RNA Biology|September 3, 2020
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Annekatrin Schott, Simon Müller, et al.
Nature Communications|May 18, 2022
HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteinsUlrike Zinnall, Miha Milek, Igor Minia, et al.
Emerging Infectious Diseases|December 24, 2014
Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, GermanyJoerg Latus, Matthias Schwab, Evelina Tacconelli, et al.
Nucleic Acids Research|February 1, 2024
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicingAlice Wedler, Nadine Bley, Markus Glaß, et al.
Autophagy|October 5, 2020
Essential role of autophagy in restricting poliovirus infection revealed by identification of an ATG7 defect in a poliomyelitis patientNanna-Sophie Brinck Andersen, Sofie Eg Jørgensen, Kristian Alsbjerg Skipper, et al.
NAR Cancer|February 26, 2025
The IGF2BP1 oncogene is a druggable m<sup>6</sup>A-dependent enhancer of YAP1-driven gene expression in ovarian cancerAnnekatrin Schott, Theresa Simon, Simon Müller, et al.
Signal Transduction and Targeted Therapy|December 24, 2025
Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancerNadine Bley, Alexander Rausch, Simon Müller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2014
Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemicaJoerg Latus, Matthias Schwab, Evelina Tacconelli, et al.
European Urology Open Science|July 1, 2026
Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz TrialViktoria Menzel, Christoph Kowalski, Sophie Klara Schellack, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
RNA Biology|September 3, 2020
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Annekatrin Schott, Simon Müller, et al.
Nature Communications|May 18, 2022
HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteinsUlrike Zinnall, Miha Milek, Igor Minia, et al.
Emerging Infectious Diseases|December 24, 2014
Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, GermanyJoerg Latus, Matthias Schwab, Evelina Tacconelli, et al.
Nucleic Acids Research|February 1, 2024
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicingAlice Wedler, Nadine Bley, Markus Glaß, et al.
Autophagy|October 5, 2020
Essential role of autophagy in restricting poliovirus infection revealed by identification of an ATG7 defect in a poliomyelitis patientNanna-Sophie Brinck Andersen, Sofie Eg Jørgensen, Kristian Alsbjerg Skipper, et al.
NAR Cancer|February 26, 2025
The IGF2BP1 oncogene is a druggable m<sup>6</sup>A-dependent enhancer of YAP1-driven gene expression in ovarian cancerAnnekatrin Schott, Theresa Simon, Simon Müller, et al.
Signal Transduction and Targeted Therapy|December 24, 2025
Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancerNadine Bley, Alexander Rausch, Simon Müller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 15, 2014
Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemicaJoerg Latus, Matthias Schwab, Evelina Tacconelli, et al.
European Urology Open Science|July 1, 2026
Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz TrialViktoria Menzel, Christoph Kowalski, Sophie Klara Schellack, et al.
Pageof 9